Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Absorbed doses in the marrow during 131I therapy

A C McEwan

    The British Journal of Radiology
    |May 1, 1977
    PubMed
    Summary

    New calculations show higher red marrow doses from radioactive iodine (131I) therapy for hyperthyroidism. These updated absorbed dose estimates are crucial for refining patient treatment and understanding potential risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Some reflections on the role of the Scientific Advisory Panel to the Marshall Islands nationwide radiological study.

    Health physics·1997
    Same author

    Lifetime risks of leukemia and cancer from diagnostic x rays.

    Health physics·1994
    Same author

    137Cs concentration in southern Chile.

    Health physics·1994
    Same author

    Health physics aspects of nuclear issues in New Zealand over the last decade.

    Australasian physical & engineering sciences in medicine·1986
    Same author

    The effect of scattered radiation in 60Co beams on wall correction factors for ionization chambers.

    Medical physics·1986
    Same author

    The system of radiation dose standardisation in New Zealand.

    Australasian physical & engineering sciences in medicine·1985

    Area of Science:

    • Nuclear medicine
    • Medical physics
    • Endocrinology

    Background:

    • Radioactive iodine (131I) therapy is a standard treatment for hyperthyroidism.
    • Accurate absorbed dose calculations are essential for optimizing therapeutic efficacy and minimizing side effects.
    • Previous dose estimates may not reflect the most current data and methodologies.

    Purpose of the Study:

    • To re-evaluate absorbed doses to red marrow and blood from 131I therapy.
    • To compare new dose estimates with previously published data.
    • To discuss uncertainties associated with the dose calculations.

    Main Methods:

    • Utilized recently available data for dose calculations.
    • Performed re-evaluation of absorbed doses to red marrow and blood.
    • Analyzed uncertainties in the computational methods.

    Main Results:

    • The mean absorbed dose to red marrow for hyperthyroid patients is estimated at 0.59 rad mCi-1.
    • The mean absorbed dose to red marrow for euthyroid states is estimated at 0.36 rad mCi-1.
    • Comparison with previous estimates highlights differences in calculated absorbed doses.

    Conclusions:

    • Updated absorbed dose calculations provide a more refined estimate for red marrow exposure during 131I therapy.
    • The findings underscore the importance of using current data for accurate dosimetry in nuclear medicine.
    • Further investigation into uncertainties can improve the precision of radiation dose estimations.

    Related Experiment Videos